Inpharma Weekly

, Volume 1625, Issue 1, pp 12–12 | Cite as

Ofatumumab active in relapsed or refractory B-cell CLL

Media release
  • 4 Downloads

Keywords

Rheumatoid Arthritis Arthritis Lymphoma Monoclonal Antibody Chronic Lymphocytic Leukaemia 

Copyright information

© Adis International Ltd 2008

Personalised recommendations